Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens

Abstract

These results, along with the observation of no increased incidence of opportunistic infections or neoplasms, suggest that ExP is not broadly immunosuppressive and does not prevent primary responses to vaccination or other antigenic challenges.